Rapport Therapeutics, Inc. (RAPP)
39.50
+0.01
(+0.03%)
USD |
NASDAQ |
May 29, 16:00
39.44
-0.06
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics Total Liabilities (Quarterly) : 26.08M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint, Inc. | 57.74M |
| Biofrontera, Inc. | 18.72M |
| ANI Pharmaceuticals, Inc. | 859.67M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 497.60M |
| Shareholders Equity (Quarterly) | 471.51M |
| Debt to Equity Ratio | 0.0229 |
| Current Ratio | 27.08 |
| Net Debt Paydown Yield | -0.12% |